Sign in
ASBP Stock Price, Chart, Stats & News
Aspire BioPharma, Inc.
Save
Aspire BioPharma, Inc. (ASBP) does not currently pay a dividend.
1.00M
Market cap
–
Current P/E
–
Forward P/E
ASBP chart
Fundamentals
Gross margin | 45.54% |
Operating margin | -206652.65% |
Pretax margin | -1056738.07% |
Net margin | -1478814.32% |
Effective tax rate | 0.00% |
ROA | -1194.43% |
ROE | 388.19% |
D/E | -0.12x |
Interest coverage ratio | -1.44x |
ASBP valuation
P/E | – |
P/S | 1628.58x |
P/B | -15.78x |
P/CF | -126.17x |
P/FCF | -2.20x |
P/OCF | -126.17x |
PEG | -2.58x |
EV multiple | -0.15x |
About
Aspire Biopharma Holdings, Inc. is an emerging pharmaceutical enterprise dedicated to pioneering and commercializing innovative sublingual drug delivery systems within the United States. Its flagship product, Instaprin, is an advanced sublingual aspirin formulation known for being soluble, pH neutral, and rapidly absorbed, making it effective for both cardiovascular emergencies and general pain management. The company is diligently developing a diverse pipeline of orally dissolving formulations.
Similar securities
Based on sector and market capitalization
Report issue